Clinical impact of an Enhanced Recovery Protocol implementation for nephrectomy and radical prostatectomy.

Durée moyenne de séjour Enhanced recovery after surgery Length of stay Nephrectomy Néphrectomie Prostatectomie Radical prostatectomy Réhabilitation accélérée après chirurgie

Journal

The French journal of urology
ISSN: 2950-3930
Titre abrégé: Fr J Urol
Pays: France
ID NLM: 9918752079106676

Informations de publication

Date de publication:
27 Jun 2024
Historique:
received: 19 01 2024
revised: 19 06 2024
accepted: 20 06 2024
medline: 30 6 2024
pubmed: 30 6 2024
entrez: 29 6 2024
Statut: aheadofprint

Résumé

Enhanced recovery after surgery (ERAS) is a combination of multimodal pathways to improve surgical outcomes. Recommendations for radical cystectomy have been published by the ERAS society for the cystectomy but a lack of evidence is observed for urological procedures such as nephrectomy (Ne) and radical prostatectomy (RP). The aim of our study was to evaluate the impact of enhanced recovery protocol implementation for Ne ad RP at our academic institution. We performed a retrospective, monocentric, comparative analysis, pre and post implementation of an enhanced recovery protocol for patients undergoing robotic-assisted radical prostatectomy or nephrectomy (partial or total) for cancer. The primary endpoint was the mean length of stay (LOS). Secondary endpoints included 30-days readmission, postoperative complications, 90 days survival, and oncologic outcome at 6 months. We included 264 patients between January, 2019, and December, 2020. Statistical analysis was performed separately by type of surgery. The LOS of patients included in the ERP protocol was decreased on average by 1,3 days IC95% [ -2.50; -0.08], p<0.001 for nephrectomies and by 2.2 days IC95% [-3.72; -0.62] p<0.001 for prostatectomies, compared to non-ERP patients. There were no more re-admisson, death or oncologic recurrence. In our experience, ERP for oncological nephrectomy and prostatectomy reduced the length of stay, without increasing postoperative complications and readmission.

Sections du résumé

BACKGROUND BACKGROUND
Enhanced recovery after surgery (ERAS) is a combination of multimodal pathways to improve surgical outcomes. Recommendations for radical cystectomy have been published by the ERAS society for the cystectomy but a lack of evidence is observed for urological procedures such as nephrectomy (Ne) and radical prostatectomy (RP). The aim of our study was to evaluate the impact of enhanced recovery protocol implementation for Ne ad RP at our academic institution.
METHODS METHODS
We performed a retrospective, monocentric, comparative analysis, pre and post implementation of an enhanced recovery protocol for patients undergoing robotic-assisted radical prostatectomy or nephrectomy (partial or total) for cancer. The primary endpoint was the mean length of stay (LOS). Secondary endpoints included 30-days readmission, postoperative complications, 90 days survival, and oncologic outcome at 6 months.
RESULTS RESULTS
We included 264 patients between January, 2019, and December, 2020. Statistical analysis was performed separately by type of surgery. The LOS of patients included in the ERP protocol was decreased on average by 1,3 days IC95% [ -2.50; -0.08], p<0.001 for nephrectomies and by 2.2 days IC95% [-3.72; -0.62] p<0.001 for prostatectomies, compared to non-ERP patients. There were no more re-admisson, death or oncologic recurrence.
CONCLUSION CONCLUSIONS
In our experience, ERP for oncological nephrectomy and prostatectomy reduced the length of stay, without increasing postoperative complications and readmission.

Identifiants

pubmed: 38944244
pii: S2950-3930(24)00131-1
doi: 10.1016/j.fjurol.2024.102674
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102674

Informations de copyright

Copyright © 2024. Published by Elsevier Masson SAS.

Auteurs

Lucie Vangheluwe (L)

Service d'Urologie, CHU de Rouen - Hopital Charles Nicolle, France. Electronic address: Lucie.vangheluwe@chu-rouen.fr.

Mathilde Legeay (M)

Service d'Anesthésie réanimation, CHU de Rouen - Hopital Charles Nicolle, France.

Louis Surlemont (L)

Service d'Urologie, CHU de Rouen - Hopital Charles Nicolle, France.

Hugo Dupuis (H)

Service d'Urologie, CHU de Rouen - Hopital Charles Nicolle, France.

Guillaume Defortescu (G)

Service d'Urologie, CHU de Rouen - Hopital Charles Nicolle, France.

Jean Nicolas Cornu (JN)

Service d'Urologie, CHU de Rouen - Hopital Charles Nicolle, France.

Christian Pfister (C)

Service d'Urologie, CHU de Rouen - Hopital Charles Nicolle, France.

Classifications MeSH